Cecilia Tortajada
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Cecilia Tortajada has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
A Bosch
Enteric Virus Laboratory of the Department of Microbiology of the University of Barcelona, Barcelona, Spain
1 shared publication- Albert Bosch
University of Barcelona
1 shared publication Edgar Palacín
Laboratori de Microbiologia, Institut Universitari Dexeus-USP, Barcelona, España
1 shared publication- Elia Díez
Agència de Salut Pública de Barcelona, Barcelona, Spain
1 shared publication J Caylà
Public Health Agency of Barcelona, Barcelona, Spain
1 shared publication- Joan Artur Caylà
Tuberculosis Research Unit Foundation of Barcelona, 08008 Barcelona, Spain
1 shared publication
Latest Publications
- 31 March 2012
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 30 (3) , 143-146
Brote nosocomial por Listeria monocytogenes en una Unidad de Neonatos
- 31 March 2012
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 30 (3) , 143-146
Brote nosocomial por Listeria monocytogenes en una Unidad de Neonatos
- Open Access
- 20 January 2012
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 12 (1) , 11
Hepatitis a among men who have sex with men in Barcelona, 1989-2010: insufficient control and need for new approaches
Men who have sex with men (MSM) are a known group at risk for hepatitis A and outbreaks among this group are frequent. In Barcelona, vaccination for MSM has been recommended since 1994. In 1998 a vaccination campaign among preadolescents was implemented and an immunization program in gay bathhouses began in 2004. Objective: to asses the incidence of hepatitis A in adults in Barcelona from 1989 to 2010 and to evaluate the outbreaks among MSM including all genotypes involved.
- 20 January 2012
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 12 (1) , 11
Open AccessHepatitis a among men who have sex with men in Barcelona, 1989-2010: insufficient control and need for new approaches
Men who have sex with men (MSM) are a known group at risk for hepatitis A and outbreaks among this group are frequent. In Barcelona, vaccination for MSM has been recommended since 1994. In 1998 a vaccination campaign among preadolescents was implemented and an immunization program in gay bathhouses began in 2004. Objective: to asses the incidence of hepatitis A in adults in Barcelona from 1989 to 2010 and to evaluate the outbreaks among MSM including all genotypes involved.
- Open Access
- 16 April 2009
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 14 (15) , 19175
Outbreak of hepatitis A among men who have sex with men in Barcelona, Spain, September 2008 – March 2009
Between 1 September 2008 and 9 March 2009, 150 cases of hepatitis A were reported in Barcelona, representing a threefold increase compared with the same period in the previous two years. The majority of the cases occurred in adult men, including 87 who reported having sex with men. This indicated the possibility of an outbreak ongoing in the population of men who have sex with men (MSM) and emphasised the need to target this community with more effective vaccination programmes.
- 16 April 2009
- Published by European Centre for Disease Control and Prevention (ECDC) in Eurosurveillance
- Vol. 14 (15) , 19175
Open AccessOutbreak of hepatitis A among men who have sex with men in Barcelona, Spain, September 2008 – March 2009
Between 1 September 2008 and 9 March 2009, 150 cases of hepatitis A were reported in Barcelona, representing a threefold increase compared with the same period in the previous two years. The majority of the cases occurred in adult men, including 87 who reported having sex with men. This indicated the possibility of an outbreak ongoing in the population of men who have sex with men (MSM) and emphasised the need to target this community with more effective vaccination programmes.